Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch From Tacrolimus to Cyclosporine in Liver Transplant Recipients (DIALIVER)
NCT00171743Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Jan 2006
- Modality
- Peptides, Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in liver transplant, sponsored by Novartis. Primary endpoints: Glycemic control (HbA1c) and Insulin dosage. Started Apr 2004; status: completed.
02
Drugs
cyclosporine
03
Conditions
liver transplant
Beyond the preview
Go deeper on NCT00171743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171743.